$IRD
Opus Genetics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Durham, NC
IRD chart
What traders are saying about $IRD
Latest postsOpus Genetics, Inc. news
- Why Is Opus Genetics (NASDAQ:IRD) Up 7.20% Premarket?
Kalkine ·
- Opus Genetics Eyes 2029 Runway as Presbyopia Drop Wins FDA Approval
marketbeat.com ·
- Opus Genetics, Inc. Estimates – NASDAQ:IRD
TradingView ·
- Form 144 Opus Genetics For: 24 October By Investing.com
Investing.com Nigeria ·
- $IRD stock is down 10% today. Here's what we see in our data.
Quiver Quantitative ·
- Opus Genetics gains IND clearance for OPGx-RDH12
BioWorld News ·
- Chardan Capital maintains Buy rating on Opus Genetics, $16 price target
TradingView ·
- Opus Genetics (IRD) Stock Forecast and Price Target 2026 $IRD
MarketBeat ·
- A science chief moved to $250-an-hour consulting at Opus Genetics (IRD).
Stock Titan ·
- Sector Update: Healthcare Stocks Decline Wednesday Afternoon
Yahoo Finance ·
- Leerink Partners Maintains Opus Genetics(IRD.US) With Buy Rating, Maintains Target Price $15
Moomoo ·
- Opus Genetics to Launch RDH12 Gene Therapy Trial for Childhood Blindness
GenomeWeb ·
Opus Genetics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14.2M | $11.0M | $19.0M | $39.9M |
| Net income | -$49.6M | -$57.5M | -$10.0M | $17.9M |
| Diluted EPS | $-0.80 | $-2.15 | $-0.46 | $0.87 |
| Total assets (year end) | $50.2M | $36.9M | $53.9M | $49.0M |
| Cash and equivalents (year end) | $45.1M | $30.3M | $50.5M | $42.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Opus Genetics, Inc.
- Ticker
- IRD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Durham, NC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1228627
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC
Frequently asked questions
What exchange is Opus Genetics, Inc. listed on?
Opus Genetics, Inc. trades on the Nasdaq under the ticker symbol IRD.
What industry is Opus Genetics, Inc. in?
Opus Genetics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Opus Genetics, Inc. headquartered?
Opus Genetics, Inc.'s business address on file with the SEC is in Durham, NC.
When does Opus Genetics, Inc.'s fiscal year end?
Opus Genetics, Inc.'s fiscal year ends on December 31.
How much revenue did Opus Genetics, Inc. report?
Opus Genetics, Inc. reported $14.2M in revenue for calendar year 2025, according to its SEC filings.